BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32414824)

  • 1. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties.
    Ashigbie PG; Rockers PC; Laing RO; Cabral HJ; Onyango MA; Buleti JPL; Wirtz VJ
    BMJ Open; 2020 May; 10(5):e035132. PubMed ID: 32414824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial.
    Rockers PC; Laing RO; Ashigbie PG; Onyango MA; Mukiira CK; Wirtz VJ
    Lancet Glob Health; 2019 Apr; 7(4):e492-e502. PubMed ID: 30799142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.
    Rockers PC; Wirtz VJ; Vian T; Onyango MA; Ashigbie PG; Laing R
    BMJ Open; 2016 Nov; 6(11):e013386. PubMed ID: 27888177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
    Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
    PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis.
    Armstrong-Hough M; Sharma S; Kishore SP; Akiteng AR; Schwartz JI
    PLoS One; 2020; 15(12):e0241555. PubMed ID: 33362249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
    Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
    BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis.
    Kiragu ZW; Rockers PC; Onyango MA; Mungai J; Mboya J; Laing R; Wirtz VJ
    PLoS One; 2022; 17(4):e0266715. PubMed ID: 35443014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
    Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
    Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
    Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
    Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
    Tadesse T; Abuye H; Tilahun G
    BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
    Watsierah CA; Ouma C
    Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessing medicines for non-communicable diseases: Patients and health care workers' experiences at public and private health facilities in Uganda.
    Tusubira AK; Akiteng AR; Nakirya BD; Nalwoga R; Ssinabulya I; Nalwadda CK; Schwartz JI
    PLoS One; 2020; 15(7):e0235696. PubMed ID: 32634164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pricing and availability of some essential child specific medicines in Odisha.
    Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
    Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross-sectional drugs' dispensaries assessment and patients' perspectives.
    Hemmeda L; Koko AEA; Mohamed RF; Mohammed YIA; Elabid AOM; Omer AT; Hamida AARAH; Haiba AM; Ali EM; Abdelgadir II; Al Fanob RM; Almahadi SSM; Ali S; Mahgoub SAA
    Int J Equity Health; 2023 Oct; 22(1):216. PubMed ID: 37848939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.